Access to Medicine Foundation runs the Generic & Biosimilar Medicines Programme to analyze company action and engage manufacturers on expanding access to generic and biosimilar medicines.

The Access to Medicine Foundation is an independent non-profit organisation based in the Netherlands. We seek to transform the healthcare ecosystem by motivating and mobilising companies to expand access to their essential healthcare products in low- and middle-income countries. Over the past two decades, we have demonstrated the power of data, collaboration and persuasion to trigger action by the pharmaceutical industry and scale up access to products. Our tried-and-tested approach involves defining the actions that healthcare companies should take, analysing what companies are actually doing, and promoting best practices. To turn our insights into action, we engage with the companies we evaluate, as well as with stakeholders across the private and public sectors. Our power to make an impact has been proven in the case of Big Pharma, as demonstrated by the success of the Access to Medicine Index. We have now begun to further expand our scope and use our change-making model to move companies across a wider range of healthcare sectors. This encompasses core groups of companies across five sectors: Big Pharma, vaccine manufacturers, generic medicine manufacturers, diagnostic companies and medical gas companies. Learn more about how we are taking access to the next level 👉 accesstomedicinefoundation.org/news/taking-access-to-the-next-level-mobilising-five-essential-healthcare-sectors